Sanofi Consumer Healthcare India Limited (SANOFICONR) reported revenue of ₹236 Cr and net profit of ₹68.80 Cr for the quarter ended 2026-06-30. Figures are parsed from the company's filed results.
The statements below are read from Sanofi Consumer Healthcare India Limited’s filed results, 9 filed quarters and 2 fiscal years on record, standalone basis. Price-linked ratios are computed at the last close, sector medians across the served universe, ownership from the shareholding pattern, and any cell whose input isn’t on record shows a dash, never an estimate.
Latest: Q1 FY26-27 · filed Jul 29, 2026 · audited
| ₹ Cr | Mar2024 | Jun2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026Latest | YoYlatest |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 211 | 164 | 171 | 173 | 221 | 234 | 251 | 229 | 236 | +6.7% |
| 130 | 101 | 109 | 109 | 151 | 149 | 161 | 140 | 146 | -2.9% | |
| Operating profit | — | 63.6 | 62.1 | 64.0 | 70.2 | 85.0 | 89.8 | 88.8 | 89.3 | +27.2% |
| OPM % | — | 38.7% | 36.4% | 37.1% | 31.8% | 36.3% | 35.8% | 38.7% | 37.9% | +6.1 pp |
| Other income | 3.00 | 0.80 | 5.00 | 5.20 | 5.60 | 3.00 | 4.60 | 5.60 | 6.30 | +12.5% |
| Interest | — | 0.10 | 0.40 | 0.40 | 0.50 | 0.60 | 0.50 | 0.50 | 0.40 | -20.0% |
| Depreciation | — | 1.10 | 1.00 | 2.00 | 3.00 | 3.30 | 3.40 | 3.20 | 3.30 | +10.0% |
| Profit before tax | 83.9 | 38.9 | 62.8 | 66.8 | 78.9 | 84.1 | 90.5 | 90.7 | 91.9 | +16.5% |
| Tax % | 25.3% | 25.4% | 29.5% | 25.1% | 23.1% | 25.2% | 26.5% | 25.2% | 25.1% | +2.1 pp |
| Net profit | 62.7 | 29.0 | 44.3 | 50.0 | 60.7 | 62.9 | 66.5 | 67.8 | 68.8 | +13.3% |
| EPS (₹) | — | 12.58 | 19.25 | 21.69 | 26.36 | 27.31 | 28.87 | 29.44 | 29.87 | +13.3% |
